Earnings Season Highlights

Refresh your browser for the latest updates!
A collection of noteworthy post-earnings reactions
Published on Jun 21, 2021 at 10:25 AM
  • Analyst Update
 
Published on Jun 21, 2021 at 10:09 AM
  • Buzz Stocks
 
Published on Jun 21, 2021 at 9:01 AM
  • Monday Morning Outlook

“ 'Risk-off is front and center thanks to the hawkish words from the Fed, which came on the back of the Chinese government-led directives over prior weeks,’ said Michael Cuoco, head of hedge-fund sales for metals and bulk materials at StoneX Group. ‘Central-bank stimulus helped the markets gather steam in the spring of 2020, and now there is a bit of a macro reset.' ”

          - Bloomberg, June 17, 2021

The biggest surprise last week, judging from the reaction of the bond and commodities markets, was the Federal Reserve’s dot-plot projections following Wednesday’s Federal Open Market Committee (FOMC) meeting, which forecast two interest rate hikes in 2023. This caught market participants by surprise, as inflation expectations plummeted, sending investors out of plays such as commodity and financial names, into bonds, which helped push recently lagging tech stocks higher. Federal Reserve Chairman Jerome Powell made it a point to note these were only projections, leading some media commentators to wonder why publish such dot plots if the forecast should be taken with a grain of salt.

Regardless, the market’s reaction to the projections and Powell’s comments was that the Fed perceives more inflationary risks relative to prior meetings, perhaps contributing to a “macro reset,” as one hedge fund associate explained. Expiration week can exacerbate volatility in specific stocks and sectors, so this remains to be seen. 

“...the S&P 500 Index’s (SPX - 4,247.44) early May, all-time closing high of 4,232.60 remains important in the short term. After struggling to overtake this level early last week, Thursday and Friday’s trading sessions established a new record closing high. But Friday’s intraday low was back below 4,232.60, implying these closes are hardly convincing breakouts…With respect to the SPDR S&P 500 ETF Trust (SPY - 424.31) open interest configuration, the big call open interest at the 425-strike – which is equivalent to SPX 4,250 – stands out to me. Most of these calls were bought-to-open, implying that if the SPY remains below the 425-strike into Friday, there will be selling of S&P futures related to this call open interest, generating expiration-related headwinds for stocks.”

          - Monday Morning Outlook, June 14, 2021

From a broader-market, price-action perspective, there were few surprises during expiration week. As I observed last week, if the S&P 500 Index (SPX - 4,166.45) remained below 4,250, or the 425-strike on the SPDR S&P 500 ETF Trust (SPY - 414.92) as we moved closer to expiration, the broader market would face headwinds related to the gradual unwinding of long SPX futures associated with calls that were bought-to-open at the June 425 strike. By Tuesday’s close, the SPY found itself back below the 425-strike, after barely closing above it on Monday, June 14. A steady stream of selling followed into Friday’s low.

If sellers emerge and push the SPX back below the May closing high, potential support is between 4,170 and 4,190, or the lower boundary of the channel in place since November, plus the vicinity of the SPX’s 50-day moving average.”

          - Monday Morning Outlook, June 14, 2021

In the first five minutes after the market opened on Friday, sellers pushed the SPX down into an area of potential support from the lower boundary of a channel in place since November, as well as its 50-day moving average. The latter marked troughs on a closing basis in three of the previous four pullbacks this year. After the morning gap lower, the SPX stabilized at support well into Friday afternoon.

The bearish “tri-star” doji pattern that emerged on the SPX in April is something that continues to stand out, given the obvious loss of momentum higher we saw from late March into April. In other words, there has only been 72 points maximum upside, versus 120 points maximum downside, since the bearish “tri-star” doji pattern was completed on April 28. 

It took the index six to eight weeks to fully recover from similar bearish patterns in January and February. Bulls have a glimmer of hope that we are closer to the backend of bearish ramifications of this multi-candle sell signal, as this latest “tri-star” doji bearish pattern surfaced nearly two months ago. Coincidentally, Friday’s pullback was in the vicinity of those late-April SPX closes, as you can see by the yellow line segment in the graph below.

Unless the SPX quickly rights itself (like it has in the past) after Friday’s close below the aforementioned channel and 50-day moving average support (the first significant close below both since March 4), I see the next area of potential support between 4,056 and 4,131.  

Additionally, 4,056 is around six times its 2009 closing low, and 4,131 is a round 10% above last year’s close. In between these levels is the round 4,100 century mark, which is the site from which the SPX broke out above its channel in early April, as well as the less-popular 80-day moving average, which marked the early March trough.

With a perceived shift in how the Fed is eyeing inflation risks, one could make the case that the SPX will spend a longer period below its channel, but only time will tell. 

If buyers surface, the first area of potential resistance is between 4,193 and 4,212, or the lower boundary of its channel. The second area of resistance is between the early May closing high at 4,232, and last week’s closing high at 4,255. For what it is worth, Thursday and Friday’s candles look very similar to May 11 and May 12, which is the last time the SPX closed below the lower boundary of its channel.

MMO 621 1

“'A continued unwinding of the bearish sentiment from a few weeks ago could finally push the (Nasdaq 100 Index) NDX above the elusive 14,000 level this week. In fact, the price action around the 14,000 level since mid-February resembles that of the NDX’s behavior around 12,000 in late August through November 2020. If a breakout above 14,000 occurs, the next hesitation level could be 14,176, which is about 10% above the NDX’s 2020 close.'”

          - Monday Morning Outlook, June 14, 2021

While it was not a big surprise, per my comments last week, the Nasdaq 100 Index (NDX - 14,049.59) did take out the 14,000-millennium level. The actual surprise may be in that it did so in the context of SPX weakness, as part of a rotation into technology as bonds and a massive shift out of reflation trades. 

However, as you can see in the top pane of the graph below, the level that coincides with a round 10% above the 2020 close marked last week’s peak. But the NDX still managed to close above the formerly elusive 14,000 level each day last week, unlike the one-day and two-day closes above that level in April, that were quickly greeted with selling activity.

MMO 621 2

With the NDX trading in an area of resistance, and the SPX experiencing a disappointing close below a first area of potential support last week, a legitimate question to ask is who will come in to drive these indices through resistance and off support, respectively.

I ask this question because fast-money traders are at or near an optimistic extreme. For example, a weekly National Association of Active Investment Managers (NAAIM) survey revealed a reading of nearly 99, or fully invested. There is room for these managers to move into a leveraged bullish position, but one wonders if they will, after the market dropped soon after they were leveraged long in late April.

Moreover, per the graphs below, option buyers are approaching optimistic extremes on both NDX and SPX components, as buy-to-open put/call volume ratios are approaching recent record low levels. Relatively low readings usually precede short-term weakness, but the direction of the ratio is also important. Currently, the direction favors bulls, but consider the color of the waving flag as yellow, implying caution is now warranted, especially with the Cboe Volatility Index (VIX - 20.70) closing above 20.14, or half its 52-week closing high of 40.28 in October.

MMO 621 3

Continue reading:

Published on Jun 21, 2021 at 7:51 AM
  • Buzz Stocks

Today's Stock Market News & Events: 6/21/2021

by Schaeffer's Digital Content Team

This last full week of June will bring plenty of economic data. Investors will be listening to updates from several Presidents of the Federal Open Market Committee (FOMC) throughout this week, especially after the recent Fed decision sent stocks spiraling. Meanwhile, there will be a handful of notable quarterly reports to unpack, including CarMax (KMX), Darden Restaurants (DRI), FedEx (FDX), and Nike (NKE), throughout this week. 

No economic data is scheduled to be released today after a wild triple-witching Friday to close out last week. Amazon Prime Day will kick off today, kicking off promotions for other big box retailers, too.

The following company is slated to release quarterly earnings today, June 21:

Luminex Corp. (NASDAQ:LMNX -- $36.79) develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. Luminex will report its Q2 earnings of 2021 after the market closes today.

The following companies released their quarterly earnings last week:

Commercial Metals Co. (NYSE:CMC -- $31.35) manufactures, recycles, and fabricates steel and metal products, and related materials and services. Commercial Metals reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.21. The company had revenue of $1.85 billion for the quarter, compared to analyst estimates of $1.74 billion.

Jabil Inc. (NYSE:JBL -- $56.56) provides manufacturing services and solutions worldwide. Jabil reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.26. The firm had revenue of $7.21 billion for the quarter, compared to the consensus estimate of $6.95 billion.

The Kroger Co. (NYSE:KR -- $37.55) operates as a retailer in the United States. Kroger reported $1.19 EPS for the quarter, beating the consensus estimate of $0.99 by $0.20. The company had revenue of $41.30 billion for the quarter, compared to analyst estimates of $39.87 billion.

Adobe Inc. (NASDAQ:ADBE -- $543.33) operates as a diversified software company worldwide. Adobe reported $3.03 earnings per share for the quarter, beating the consensus estimate of $2.81 by $0.22. The company had revenue of $3.84 billion for the quarter, compared to analysts' expectations of $3.73 billion.

Smith & Wesson Brands Inc. (NASDAQ:SWBI -- $20.55) designs, manufactures, and sells firearms worldwide. Smith & Wesson Brands reported $1.71 EPS for the quarter, topping analysts' consensus estimates of $1.02 by $0.69. The firm had revenue of $322.95 million for the quarter, compared to analysts' expectations of $259.80 million.

Looking ahead to tomorrow, Tuesday will bring existing home sales, as well as an update from Federal Reserve Chairman Jerome Powell. All economic dates listed here are tentative and subject to change.

In case you missed it last week, Schaeffer's Market Mashup podcast dropped a brand-new episode last week continuing our partnership with Cboe Global Markets!

Cboe's Henry Schwartz and Robert Hocking join Schaeffer's Patrick Martin to discuss the biggest mistakes options traders make when starting out. We learn the lessons they'd give to their past selves (1:33), Rob's top five mistakes he sees options traders make (4:11), Henry's own list (7:16), the broader surge in market participation from retail traders (15:00), and how to further educate yourself (19:25). Schaeffer's Market Mashup podcast comes out approximately twice a month, so be sure to subscribe to avoid missing the next episode drop!

Published on Jun 18, 2021 at 3:28 PM
Updated on Jun 18, 2021 at 3:34 PM
  • 5-Minute Market Rundown

This week was packed with not so sunny news, though a bright spot did shine through on Monday, as the S&P 500 and Nasdaq both scored record highs. Meanwhile, the Dow  logged a small loss as investors held their breath over a two-day Federal Reserve policy meeting. That anxiety carried over to the next session, with all three major indexes falling as the Nasdaq also snapped a three-day win streak.

Investors' worries were not all for naught, however, as Wednesday saw the Federal Open Market Committee (FOMC) signal interest rates could rise sooner than expected, sinking down stocks. On Thursday, the blue-chip index fell even lower after the release of worse-than-expected weekly jobless claims data. Though Big Tech jumped toward the end of the session, pushing the Nasdaq to a win, the Dow logged its fourth-straight loss. As of Friday afternoon, the Dow was down nearly 500 points, pacing for its worst week in over four months, after more interest rate news signaled hikes could be closer still. In response, all three major benchmarks were eyeing substantial weekly losses.

Options Traders Get Speculative 

Options traders were eager to speculate this week, with plenty of action from both bulls and bears. Amid the meme stock craze, Corsair Gaming (CRSR) caught the attention of investors. Nucor (NUE), meanwhile, attracted bears, despite receiving a bull note from Morgan Stanley. Put traders also blasted Lennar (LEN), even after it reported a fiscal second-quarter earnings beat. Lastly, streaming name FuboTV (FUBO) has been muted for most of the month, though that didn't stop options bulls from tuning in.

 

Checking In on Pharma Stocks

A number of pharmaceutical stocks made headlines this week. Once a Reddit darling, Orphazyme (ORPH) got hit after the Food and Drug Administration (FDA) rejected the company's experimental genetic disorder drug candidate. Sage Therapeutics (SAGE), which is closely tied to Biogen (BIIB), was also rocked after reporting dismal late-stage trial results for its depression drug. Meanwhile, Covid-19 vaccines were also in focus. Ocugen (OCGN) struck a manufacturing partnership deal with Jubilant HollisterStier, though its vaccine candidate has not yet been approved. Plus, CureVac (CVAC) stock plummeted, after its vaccine proved to be only 47% effective in a clinical trial.

A Period of Low Volatility Could Be Right Around the Corner

Earnings reports will continue to trickle in next week, with CarMax (KMX), Darden Restaurants (DRI), FedEx (FDX), and Nike (NKE) all set to report. However, investors may be more focuses on FOMC updates, given the recent Fed news. In the meantime, see why Schaeffer's Senior Quantitative Analyst Rocky White's thinks a period of low volatility may be ahead. Traders should also check out what was expected heading into June expiration week

Published on Jun 18, 2021 at 1:56 PM
  • Buzz Stocks

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues to take shape in 2021.

Investor interest in the cannabis industry is growing at an explosive rate, and the leading players continue to break through legal barrier after legal barrier, especially in the United States. More than 40 U.S. states legalized recreational and/or medical marijuana by the end of 2020. Now, more and more companies are starting to see the opportunity in cannabis cultivation, marketing, distribution, and technology.

This week, we saw a lot of legislation momentum across multiple U.S. states. Over in Rhode Island on Monday, a bill for the adults-only usage of cannabis reached General Assembly floor for the first time ever. Rhode Island Governor Dan McKee is eager to sign the bill into law. The bill will provide guidance for the retail licensing with a focus on using a specific social equity assistance fund.

Louisiana Governor John Bel Edwards signed a marijuana decriminalization bill on June 14. What is specifically being decriminalized in the state of Louisiana is the possession of a small amount, defined as under 14 grams, of cannabis for personal use. Violations of this law will simply result in fines, not jail time.

Here is a quick roundup of major (and action-worthy!) cannabis stock news this week:

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced the appointment of Steven Schoch to the Company's Board of Directors and as Chair of the Audit Committee on June 14. Mr. Schoch brings more than 20 years of financial and operational leadership and expertise across various areas in biopharmaceuticals, media, and technology, including building and scaling businesses and leading innovation. ARNA was last seen trading around $65.97.

On June 15, The Supreme Cannabis Company, Inc. (TSX:FIRE), announced that it had been granted the final court order from the Ontario Superior Court of Justice approving the plan of arrangement with Canopy Growth Corporation (NYSE:CGC), Canopy will acquire all of the issued and outstanding common shares of Supreme for consideration consisting of 0.01165872 of a Canopy common share and $0.0001 in cash in exchange for each Supreme Share held, which was previously announced on April 8. CGC was last seen down 3% to trade at $23.19.

Coffee Holding Co., Inc. (NASDAQ:JVA), a fairly new player in the cannabis stocks arena, announced its operating results for the past three months and six months on June 14. Net sales totaled $14.4 million for the past three months, a decrease of $5.6 million or 28%, from $20 million last year. According to the CEO, "We are currently planning our official initial launch of our CBD infused brands during our third fiscal quarter of 2021. We have identified at least 27 states, that subject to certain restrictions, will allow sales of CBD beverage products as we prepare our go-to-market strategy for our CBD infused brands." JVA was last seen down 2.9% to trade at $5.25.

On June 14, Cronos Group Inc. (NASDAQ:CRON) and PharmaCann Inc, one of the largest vertically integrated cannabis companies in the United States, announced that the companies have entered into an agreement under which a wholly-owned subsidiary of CRON has purchased an option to acquire an approximately 10.5% ownership stake in PharmaCann on a fully-diluted basis. CRON is down 1% to trade at $8.48.

HEXO Corp. (NYSE:HEXO) reported its financial results for the third quarter of fiscal 2021 on June 14. Total net sales declined $10.2 million from the previous quarter. HEXO's total net loss remained flat quarter-over-quarter. HEXO kicked off trading this week ahead of earnings at $5.97 after a gap down from last week's closing price of $6.60. HEXO stock was trading around $6 most of the week, but is down 7% to trade at $5.66 as the week ends.

Innovative Industrial Properties, Inc. (NYSE:IIPR), the first and only real estate company on the New York Stock Exchange focused on the regulated U.S. cannabis industry, announced on June 15 that its board of directors has declared a second quarter dividend of $1.40 per share of common stock, representing an approximately 6% increase over IIPR's first quarter dividend payout of $1.32 per share of common stock, and an about 32% increase over IIPR's second-quarter of 2020 dividend of $1.06 per share of common stock. IIPR was last seen trading at $186.32.

Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company that develops synthetic cannaboids, announced on June 15 that AMRS has executed a binding term sheet for the acquisition of award-winning, clean wellness company OLIKA Inc. On June 17, Amyris also announced its partnerships with the UNCF (United Negro College Fund) and 10,000 Degrees® to establish a $180,000 scholarship fund to support black and African American students pursuing higher education across STEM (science, technology, engineering, and math), business, and marketing studies. While AMRS took a dip mid-week this week, Amyris stock has breached the $16 level in today's negative price action.

In other cannabis news unrelated to the stock market (so far), 'Tiger King' star, Joe Exotic, announced that he will be releasing a cannabis line from prison. Paul Pierce, a former player on the Boston Celtics, also announced he will be launching a cannabis brand himself.

Published on Jun 18, 2021 at 11:40 AM
  • The Week Ahead

The last full week of June will bring plenty of economic data. Investors will be listening to updates from several Presidents of the Federal Open Market Committee (FOMC) throughout the week, especially after the recent Fed decision sent stocks spiraling. Meanwhile, there will be a handful of notable quarterly reports to unpack, including CarMax (KMX), Darden Restaurants (DRI), FedEx (FDX), and Nike (NKE). 

Below is a list of key market events scheduled for the upcoming week. All economic dates listed below are tentative and subject to change.

 The week will start off slow on Monday, June 21, with nothing scheduled.

Tuesday, June 22, will bring existing home sales, as well as an update from Federal Reserve Chairman Jerome Powell. 

Wednesday, June 23, new home sales data, Markit manufacturing PMI, and Markit services PMI are slated for release. 

Finally, Thursday, June 24, the usual initial and continuing jobless claims data are due out, as well as durable goods orders, and the revised GDP. 

Friday, June 25, will feature personal income, consumer spending, and consumer sentiment data. 

Published on Jun 18, 2021 at 11:00 AM
  • Buzz Stocks
 
Published on Jun 18, 2021 at 10:38 AM
  • Analyst Update
 
Published on Jun 18, 2021 at 10:21 AM
  • Buzz Stocks
 
Published on Jun 18, 2021 at 9:53 AM
Updated on Jun 18, 2021 at 9:53 AM
  • Buzz Stocks

The shares of Orphazyme A S ADR (NASDAQ:ORPH) are dramatically lower this morning, slammed by news that the Food and Drug Administration (FDA) rejected the firm's experimental genetic disorder drug candidate, arimoclomol. The Danish biotech has recently been dubbed a meme stock, surging to an unprecedented high of $77.77 earlier in the month. One analyst from Nordnet now calls the situation "hopeless," as the FDA's decision has left ORPH with no money or documentable projects, adding that its "game over for 'meme speculation'."

The security was last seen down 38.9%  at $8.40, putting it even closer to its lows near the $5 level. ORPH just breached its 70-day moving average, too, which looked for a second like it could support the stock's pullback from its early June surge. Orphazyme stock is still up 57.5% in the last month, however. 

This drop could lead to price-target cuts. The 12-month consensus price target of $10.50 is a whopping 45.8% to last night's close. Meanwhile, of the three analysts in coverage, there is only one "buy" rating  on the books. 

While short interest has waned from its March highs, it shot up in the last reporting period to 35,295 shares sold short. There's a good possibility more short sellers will pile on, should this negative price action continue, as these shares only make up 0.1% of the stock's available float. It should be noted, however, ORPH has landed on the short-sell restricted (SSR) list today. 

 

Published on Jun 18, 2021 at 9:39 AM
  • Editor's Pick
  • Bernie's Content
  • Best and Worst Stocks

As we kicked off 2021, we highlighted two top contrarian picks for the new year. Founder and CEO delivered one pick, Charles Schwab Corporation (NYSE:SCHW). Six months into the year, the bank stock has delivered a tidy gain of 35%. To access the entirety of the 2021 report, click here. Below, Bernie checked in on SCHW, while looking ahead to see what the stock has left for the final six months of 2021.

With my top pick SCHW trading in the low $50’s as 2020 had drawn to a close, I concluded my comments in the above space as follows: “The May 2018 all-time high at $60 is already within sights – with additional upside potential to the $70 area as the year progresses.”

My bullish assessment has proven too conservative, as the shares soon embarked upon a “take no prisoners” rally which peaked in early-June just above $76. 

While our equity analysis and price projections are deeply founded in technical and sentiment analysis, we believe the fact that SCHW added 3.2 million new brokerage accounts in the first quarter 2021 – more new accounts than all of 2020 – added fuel to the already bullish technicals. We suggest that the retail investor boom is just getting started, and in this regard, we turn back the clock and note another price peak in SCHW – this one at $49.26 in April 1999, back in the days of the so-called “dot-com boom” – a stock trading craze that never approached the level of individual investor market participation that we now routinely experience.

True to this year’s form, the pullback by SCHW since the June peak has been quite modest. And while we do see the potential for a 10% pullback from the highs to the $68-$69 area (further buttressed by support at the steadily rising 50-day and 80-day moving averages), we expect more in the way of all-time high action from SCHW in the second half. Our first upside target is in the $80-area, at which point SCHW would be sporting a market capitalization of about $150 billion and a year-to-date gain of 50%.

SCHW Stock

 

Begin the New Year With Schaeffer's 7 FREE 2022 Stock Picks!

1640638248

 


MORE | MARKETstories


Trump's 'Golden Dome' Places 3 Defense Stocks in Focus
L3Harris shares are enjoying tailwinds today
3 Oil Stocks You Should Be Watching
EQT, TTE, and FANG are three oil & gas stocks investors should know